- Home
- UUUU vs BLTE Comparison
UUUU vs BLTE Comparison
Compare UUUU & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UUUU | BLTE |
|---|---|---|
| Founded | 1987 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 4.1B |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | UUUU | BLTE |
|---|---|---|
| Price | $21.10 | $154.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $16.00 | ★ $156.00 |
| AVG Volume (30 Days) | ★ 10.1M | 247.9K |
| Earning Date | 02-25-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $78,742,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $174.53 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 103.69 | N/A |
| 52 Week Low | $3.20 | $49.00 |
| 52 Week High | $27.33 | $170.25 |
Technical Indicators
Market Signals| Indicator | UUUU | BLTE |
|---|---|---|
| Relative Strength Index (RSI) | 72.01 | 51.71 |
| Support Level | $17.75 | $146.06 |
| Resistance Level | $19.96 | $170.25 |
| Average True Range (ATR) | 1.41 | 7.45 |
| MACD | 0.52 | -1.98 |
| Stochastic Oscillator | 93.64 | 30.76 |
Price Performance
Historical ComparisonAbout UUUU Energy Fuels Inc (Canada)
Energy Fuels Inc is a United States-based critical minerals company. The Company mines uranium and produces natural uranium concentrates that are sold to nuclear utilities for the production of carbon-free nuclear energy. It holds two of America's key uranium production centers: The White Mesa Mill in Utah, and the Nichols Ranch ISR Facility in Wyoming. It has three reportable segments based on its operations and financial information; Uranium, HMS, and REE.
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.